SCN1A and encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy: Screening for ATP6V0C mutations would help differentiating patients with Dravet syndrome caused by SCN1A mutations, which presented similar clinical manifestation but different responses to antiepileptic treatment.